# Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function

> **NCT01280344** · PHASE2 · COMPLETED · sponsor: **Helsinn Therapeutics (U.S.), Inc** · enrollment: 320 (actual)

## Conditions studied

- Gastrointestinal Dysmotility

## Interventions

- **DRUG:** Saline Solution for Injection
- **DRUG:** Ipamorelin

## Key facts

- **NCT ID:** NCT01280344
- **Lead sponsor:** Helsinn Therapeutics (U.S.), Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-06
- **Final completion:** 2014-05
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01280344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01280344, "Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01280344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*